Delivery Order SPE2DX22D0010-SPE2D826FAR51
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Nucynta Tabs 75mg, a pain management pharmaceutical. This competitively awarded, non-set-aside contract carries a ceiling value of $12,375.14 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $13,932.13 for Nucynta Tabs 75mg, a pain management pharmaceutical product. This firm fixed-price delivery order, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitive procurement with no set-aside designation. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,070.28 to AmerisourceBergen Drug Corp for Nucynta Tabs 100mg, a prescription pain management medication. This competitively awarded, firm fixed-price contract was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Nucynta Tabs 75mg, a narcotic pain management pharmaceutical. This competitively awarded, firm fixed-price delivery order has a ceiling value of $10,546.33 and is scheduled for completion by November 6, 2025. The contract is not designated as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $7,938.87, represents a non-competitive set-aside contract and is scheduled for completion by October 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,101.84 for Nucynta ER Tabs 250mg, a pain management pharmaceutical. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Nucynta 75 mg tablets (100-count units) valued at $30,223.35. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,982.00 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Nucynta Tabs 50mg, a prescription pain management pharmaceutical. This non-set-aside, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,315.96 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg, a pain management pharmaceutical. Issued on August 27, 2025, with an ultimate completion date of August 28, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $4,764.50 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Nucynta 75 mg tablets (100 count). This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, represents a pediatric pain management pharmaceutical product for military healthcare needs. The award was made through open competition with no set-aside designation, and the product will be delivered to...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAR51Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,895.80 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Nucynta Tabs 75mg, a pain management pharmaceutical. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by October 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of federal contract awards predominately with DLA and its Medical Supply Chain, demonstrating proven capability to meet federal healthcare supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 10/28/25 |